Home / Brands / Janssen Pharmaceuticals
Janssen Pharmaceuticals Recalls
4 recalls on record · August 13, 2014 to November 14, 2018 · Drugs
Recalls by year
14
15
18
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
November 14, 2018DrugsFDA
Janssen Pharmaceuticals, Inc. recalls Ortho-Novum 7/7/7 (norethindrone/ethinyl/estradiol) Tablets, 0.5 mg/0.035 mg, 0.75 mg/0.035 mg, 1 mg/0.035, 28-Day Regim
Hazard: Labeling: Incorrect Instructions; Instructions included for use with the Veridate dispenser contained instructions for the Dialpak dispenser.
November 14, 2018DrugsFDA
Janssen Pharmaceuticals, Inc. recalls Ortho-Novum 1/35 (norethindrone/ethinyl estradiol) Tablets, 1 mg/0.035 mg, 28-Day Regimen per pouch (NDC 50458-176-28),
Hazard: Labeling: Incorrect Instructions; Instructions included for use with the Veridate dispenser contained instructions for the Dialpak dispenser.
May 20, 2015DrugsFDA
Janssen Pharmaceuticals, Inc. recalls Ortho-Cept (0.15 mg desogestrel and 0.03 mg ethinyl estradiol) tablets, 28- count blister (21 active tablets and 7 place
Hazard: Subpotent Drug
August 13, 2014DrugsFDA
Janssen Pharmaceuticals, Inc. recalls Risperdal CONSTA (risperiDONE), 25 mg Dose Pack, Rx Only, Single Use Only Janssen Pharmaceuticals Inc., Titusville, NJ
Hazard: Non-Sterility: Janssen is recalling one lot of Risperdal CONSTA (risperiDONE) due to a sterility failure in a stability sample